Digital Transformation in Pharma Industry
We specialize in Computerized System Validation (CSV) and Quality Assurance (QA) support services to our global customers in the life-sciences industry.
Each Vimachem digital transformation project starts with an assessment of the customer digital maturity.
Each Vimachem digital transformation project begins with an assessment of the customer’s digital maturity. This evaluation is structured around three clearly defined business dimensions:
Assessing the existing technological infrastructure, digital capabilities, and integration readiness.
Evaluating processes, workflows, and efficiency to identify areas for digital optimization.
Reviewing the company's culture, leadership alignment, and readiness to embrace digital change.
Digital maturity assessment
The Digital Maturity Assessment serves as a crucial tool, providing clear guidelines for navigating the digital transformation journey in pharma.
Leveraging insights from the Digital Maturity study, our Pharma 4.0 experts collaborate closely with site-level teams to conduct a gap analysis. This process quickly identifies areas for improvement, highlighting key opportunities to enhance digital transformation in the pharmaceutical industry.
The discovered opportunities are then used to initiate digital transformation pilot projects, ensuring a structured and efficient approach to digital transformation in pharma manufacturing.
At Vimachem, we understand that digital transformation in biopharma and pharmaceutical digital transformation doesn't require a full-scale plant overhaul. Instead, some of the most impactful results come from pilot projects targeting underperforming operational units, transforming those units and then optimizing and scaling across lines and sites.
By successfully implementing pilot projects, organizations can scale up these initiatives to maximize the benefits of digital transformation in the pharma industry. A well-defined scale-up strategy is essential to ensure long-term success in biopharma digital transformation.
What it is like working with Vimachem
See all case studies
Sharp Sterile Establishes a Foundation for Multi-Site Manufacturing Analytics with Vimachem's OEE Platform
Sharp Sterile Manufacturing
Pharmaceutical Manufacturing
How Purna Pharmaceuticals N.V. Implemented Vimachem SSM Level 3 and Level 4 to Support Multi-Client Liquid and Cream Packaging
Purna Pharmaceuticals N.V. (Contract Manufacturer)
Pharmaceutical Manufacturing (CDMO)
From Paper-Based to Scalable Serialization! How Fulton CDMO Standardized on Vimachem Level 3 SSM & Manual Aggregation Module to Enable Compliance and Growth
Fulton Medicinali (CDMO)
Pharmaceutical Manufacturing (CDMO)
Labatec Achieves a 30% OEE Increase (86% Relative Improvement) and 324% ROI with Vimachem's Manufacturing Analytics and OEE Solution
Labatec
Pharmaceutical Manufacturing
From 41% to 65% OEE! A 59% Increase - Inside Astrea Pharma's OEE Breakthrough on their First Production Line with Vimachem's MA & OEE.
Astrea Pharma
Pharmaceutical manufacturing
How ELPEN Increased OEE by 90% and achieved 299% ROI with Vimachem's Manufacturing Analytics & OEE solution
ELPEN
Pharmaceutical manufacturing
Ensure On-Time Drug Shipments: How to Quickly Replace Your Serialization System with the Leading Track-and-Trace Platform
HELP Pharmaceuticals
Serialization Compliance in Russia with Medice and Wipotec
MEDICE Arzneimittel Pütter GmbH & Co. KG
3 weeks
Average time to upgrade for market compliance
Zero
Line stoppages to test the integration
%201.svg)
Serialization Driving Innovation & Change With RFID
Fresenius Kabi
Serialization For Global Medicines Traceability
Aspen Pharmacare Australia
Pharma Trackts 2021 | Serialization Driving Change And Innovation
IBERFAR, Indústria Farmacêutica S.A.
01 / 02
Flexible and cost-efficient pharma digital transformation
Our modules are designed for flexibility and cost-efficiency, allowing you to pay only for the features you truly need.
These modules can be deployed as standalone solutions, offering end-to-end functionality across both manufacturing and quality operations. This modular approach gives you the flexibility to select only the software components required for your specific needs, enabling you to digitalize your production step by step as part of your pharmaceutical digital transformation.
This scalable model supports your digital transformation in pharma manufacturing and ensures a smooth transition towards full digital transformation in pharmaceuticals, at a pace that works best for your organization.
Benefits of pharma digital transformation
65%
Reduction in deviations
35%
Increase in OEE of packaging lines
30%
Reduction in changeover time
